| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 22.6k | $0.00 | $0 | | 08/11/2023 |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 8.9k | $18.91 | $168.3k | | 08/11/2023 |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 1000 | $15.61 | $15.6k | | 06/30/2023 |
| 05/15/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 21k | $34.55 | $726k | | 02/02/2022 |
| 03/15/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 3k | $30.65 | $90.9k | | 03/15/2023 |
| 03/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 21.5k | $31.59 | $679.4k | | 09/22/2022 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 605 | $12.18 | $7.4k | | 12/31/2022 |
| 12/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.9k | $21.50 | $62.7k | | 12/15/2022 |
| 09/22/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 52.4k | $0.00 | $0 | | 09/22/2022 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 1000 | $11.75 | $11.7k | | 06/30/2022 |
| 03/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.8k | $15.79 | $29k | | 03/15/2022 |
| 02/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.1k | $13.35 | $28.5k | | 02/15/2022 |
| 02/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 295 | $13.35 | $3.9k | | 02/15/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 52.4k | $0.00 | $0 | | 02/02/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 57k | $13.08 | $745.8k | | 02/02/2022 |
| 12/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 513 | $15.92 | $8.2k | | 12/15/2021 |
| 11/09/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 35.9k | $0.00 | $0 | | 11/09/2021 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 882 | $24.09 | $21.2k | | 06/30/2021 |
| 04/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 411 | $28.16 | $11.6k | | 04/15/2021 |
| 02/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.1k | $28.97 | $61.9k | | 02/15/2021 |
| 02/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 275 | $28.97 | $8k | | 02/15/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 22.6k | $0.00 | $0 | | 02/02/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 40.9k | $28.01 | $1.1M | | 02/02/2021 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 348 | $21.36 | $7.4k | | 12/31/2020 |
| 12/15/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 562 | $26.75 | $15k | | 12/15/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 17.5k | $0.00 | $0 | | 09/30/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 6.1k | $25.14 | $152.1k | | 09/30/2020 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 1000 | $13.80 | $13.8k | | 06/30/2020 |
| 04/15/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 432 | $14.80 | $6.4k | | 04/15/2020 |
| 02/15/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 288 | $25.33 | $7.3k | | 02/15/2020 |
| 01/23/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 100k | $22.32 | $2.2M | | 01/23/2020 |
| 01/23/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 20k | $0.00 | $0 | | 01/23/2020 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 382 | $10.82 | $4.1k | | 12/31/2019 |
| 12/15/2019 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 576 | $15.99 | $9.2k | | 12/15/2019 |